KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy

BACKGROUND AND PURPOSE: KRAS and BRAF are mutated in 35% and 10% of colorectal cancers, respectively. However, data specifically for locally advanced rectal cancers are scarce, and the frequency of KRAS mutations in codons 61 and 146 remains to be established. MATERIALS AND METHODS: DNA was isolated...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Radiother Oncol
Main Authors: Gaedcke, Jochen, Grade, Marian, Jung, Klaus, Schirmer, Markus, Jo, Peter, Obermeyer, Christoph, Wolff, Hendrik A., Herrmann, Markus K., Beissbarth, Tim, Becker, Heinz, Ried, Thomas, Ghadimi, Michael
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7373270/
https://ncbi.nlm.nih.gov/pubmed/19913317
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2009.10.001
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares